National drug policy forum to take place in Moscow

The National drug policy forum has been held in Moscow on December 10. Tatiana Golikova, Minister of Healthcare and Social Development, has presented the main legislation initiatives carried out in this field: the Public health protection law, the Biomedical technologies law, the Compulsory medical organizations' responsibility law. Mrs Golikova has also told about the Compulsory medical insurance law and the Regional health care programs which would cost about 460 billion dollars to the government.

According to Mrs Golikova, the Russian business has already managed to adapt to new regulations, such as essential drug price registration. The minister has told there has been 7701 trade names registered to the 9th of December. She added that the process of forming essential drug list has been transparent. The government has decided to go further in changing game rules in pharmaceutical market, and tends to become one of the most active pharmaceutical manufacturers. There will be about 123 billion dollars assigned to pharmaceutical industry development in the network of 2011 federal target program.

Tatiana Golikova has formulated two main governmental tasks for pharmaceutical market: forming the list of drugs purchased for persons entitled to a benefit at local budget costs;  direct delivery of drugs with long-term delivery contracts between federal district governments and pharmaceutical manufacturers.

Tatiana Golikova has noticed that such investments are essential for the development of high quality drugs in the territory of Russia. The minister has named the adoption of unified standards of medical aid, unified compulsory medical insurance payments for non-working population, implementation of medical aid payment through the unified rate.

In conclusion Mrs Golikova has offered to pharmaceutical community to actively join the common work concerning priority area indicated by the president of Russia: elaboration and implementation of drug state purchasing mechanism and formation of the list of drugs purchased for persons entitled to a benefit at local budget costs.

Sources: "Rossijskaya Gazeta", "Pharmatsevticheskiy Vestnik".